Table 1.
Immune evaluation of the patient
| Parameter | Patient | Normal range/control |
|---|---|---|
| Lymphocyte immunophenotyping (cells/µL) | ||
| CD3 | 1903 | 700–2100 |
| CD4 | 1012 | 300–1400 |
| CD8 | 784 | 200–900 |
| CD56 | 348 | 90–600 |
| CD19/20 | 1012 | 100–500 |
| Responses to mitogens (stimulation index; P/C) | ||
| PHA | 358/500 | Stim. index > 300 Patient/control > 50% |
| Responses to antigens (stimulation index; no. responses) | ||
| Candida, CMV, zoster, simplex, tetanus, PPD | All < 20 | Stim. index > 20 Total antigen responses > 2 |
| Immunoglobulins | ||
| IgG (g/L) | 12.6 | 6.6–15.3 |
| IgA (g/L) | 1.1 | 0.54–4.17 |
| IgM (g/L) | 0.7 | 0.3–2.3 |
| Specific antibodies | ||
| Tetanus | 0.02 | >0.1 |
| Measles/mumps/rubella | +ve/−ve/+ve | +ve/+ve/+ve |
| Isohemagglutinin | 1:16 | >1:32 |